Last 12 months
Inside the activity.
0 purchase rows · 63 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 29 |
| Jan 2026 | 0 | 10 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 07, 2025 Filed Oct 9, 2025 21:09 UTC |
SANTELMO THIAGO TPresident, International
|
GrantRestricted Share Units · Derivative | 16.5979 | $0.00 | $0.00 |
DisclosureSEC source: 0002015936-25-000005 · wk-form4_1760044137.xml · derivative · entry 7 SANTELMO THIAGO T · CIK 0002015936 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,860.572 Underlying: Common Shares · 16.5979 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share units represent a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31 2025. F5 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31 2025. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
CURTIS THOMAS BENJAMINPres., BK US & CA
|
GrantPerformance Share Units · Derivative | 562.4435 | $0.00 | $0.00 |
DisclosureSEC source: 0001804729-25-000005 · wk-form4_1760044120.xml · derivative · entry 8 CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,048.1069 Underlying: Common Shares · 562.4435 shares Expires 2028-03-15 F10 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs will have a performance period beginning February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
CURTIS THOMAS BENJAMINPres., BK US & CA
|
GrantRestricted Share Units · Derivative | 86.0179 | $0.00 | $0.00 |
DisclosureSEC source: 0001804729-25-000005 · wk-form4_1760044120.xml · derivative · entry 7 CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,642.3253 Underlying: Common Shares · 86.0179 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F9 · derivative.exercise_date: These restricted share units vest in equal annual installments. The vesting will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. F9 · derivative.expiration_date: These restricted share units vest in equal annual installments. The vesting will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
CURTIS THOMAS BENJAMINPres., BK US & CA
|
GrantPerformance Share Units · Derivative | 565.4251 | $0.00 | $0.00 |
DisclosureSEC source: 0001804729-25-000005 · wk-form4_1760044120.xml · derivative · entry 6 CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,382.3309 Underlying: Common Shares · 565.4251 shares Expires 2027-03-15 F8 · derivative.exercise_price: The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
CURTIS THOMAS BENJAMINPres., BK US & CA
|
GrantRestricted Share Units · Derivative | 103.1645 | $0.00 | $0.00 |
DisclosureSEC source: 0001804729-25-000005 · wk-form4_1760044120.xml · derivative · entry 5 CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,564.406 Underlying: Common Shares · 103.1645 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F7 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. F7 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
CURTIS THOMAS BENJAMINPres., BK US & CA
|
GrantPerformance Share Units · Derivative | 432.6781 | $0.00 | $0.00 |
DisclosureSEC source: 0001804729-25-000005 · wk-form4_1760044120.xml · derivative · entry 4 CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,501.8145 Underlying: Common Shares · 432.6781 shares Expires 2026-02-22 F5 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
CURTIS THOMAS BENJAMINPres., BK US & CA
|
GrantRestricted Share Units · Derivative | 44.3915 | $0.00 | $0.00 |
DisclosureSEC source: 0001804729-25-000005 · wk-form4_1760044120.xml · derivative · entry 3 CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,976.146 Underlying: Common Shares · 44.3915 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F4 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026. F4 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
CURTIS THOMAS BENJAMINPres., BK US & CA
|
GrantRestricted Share Units · Derivative | 23.1924 | $0.00 | $0.00 |
DisclosureSEC source: 0001804729-25-000005 · wk-form4_1760044120.xml · derivative · entry 2 CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,599.7968 Underlying: Common Shares · 23.1924 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F3 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. F3 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:09 UTC |
DOYLE J PATRICKDirector · Executive Chairman
|
GrantPerformance Share Units · Derivative | 7,389.9132 | $0.00 | $0.00 |
DisclosureSEC source: 0001337160-25-000005 · wk-form4_1760044177.xml · derivative · entry 5 DOYLE J PATRICK · CIK 0001337160 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 828,385.4368 Underlying: Common Shares · 7,389.9132 shares Expires not disclosed F5 · derivative.exercise_price: The performance based restricted share units ("PBRSUs") will have a performance period beginning November 21, 2022 and ending May 21, 2028 and may be earned from 50% for the threshold performance to 200% for maximum performance, based on meeting performance targets tied to the appreciation of the price of RBI common shares. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. F5 · derivative.exercise_date: The performance based restricted share units ("PBRSUs") will have a performance period beginning November 21, 2022 and ending May 21, 2028 and may be earned from 50% for the threshold performance to 200% for maximum performance, based on meeting performance targets tied to the appreciation of the price of RBI common shares. F5 · derivative.expiration_date: The performance based restricted share units ("PBRSUs") will have a performance period beginning November 21, 2022 and ending May 21, 2028 and may be earned from 50% for the threshold performance to 200% for maximum performance, based on meeting performance targets tied to the appreciation of the price of RBI common shares. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:09 UTC |
DOYLE J PATRICKDirector · Executive Chairman
|
GrantRestricted Share Units · Derivative | 2,955.9653 | $0.00 | $0.00 |
DisclosureSEC source: 0001337160-25-000005 · wk-form4_1760044177.xml · derivative · entry 4 DOYLE J PATRICK · CIK 0001337160 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 331,354.1747 Underlying: Common Shares · 2,955.9653 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F4 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on November 21, 2025, November 21, 2026 and November 21, 2027. F4 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on November 21, 2025, November 21, 2026 and November 21, 2027. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:09 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 386.6771 | $0.00 | $0.00 |
DisclosureSEC source: 0001552022-25-000006 · wk-form4_1760044161.xml · derivative · entry 11 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,345.2524 Underlying: Common Shares · 386.6771 shares Expires 2028-03-15 F12 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs will have a performance period beginning February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:09 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 89.7944 | $0.00 | $0.00 |
DisclosureSEC source: 0001552022-25-000006 · wk-form4_1760044161.xml · derivative · entry 10 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,065.6669 Underlying: Common Shares · 89.7944 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F11 · derivative.exercise_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. F11 · derivative.expiration_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:09 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 314.1251 | $0.00 | $0.00 |
DisclosureSEC source: 0001552022-25-000006 · wk-form4_1760044161.xml · derivative · entry 9 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,212.406 Underlying: Common Shares · 314.1251 shares Expires 2027-03-15 F10 · derivative.exercise_price: The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:09 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 103.8654 | $0.00 | $0.00 |
DisclosureSEC source: 0001552022-25-000006 · wk-form4_1760044161.xml · derivative · entry 8 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,642.9744 Underlying: Common Shares · 103.8654 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F9 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. F9 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:09 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 324.5085 | $0.00 | $0.00 |
DisclosureSEC source: 0001552022-25-000006 · wk-form4_1760044161.xml · derivative · entry 7 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,376.3609 Underlying: Common Shares · 324.5085 shares Expires 2026-02-22 F7 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:09 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 70.1099 | $0.00 | $0.00 |
DisclosureSEC source: 0001552022-25-000006 · wk-form4_1760044161.xml · derivative · entry 6 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,859.0903 Underlying: Common Shares · 70.1099 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F6 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026. F6 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:09 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 43.3514 | $0.00 | $0.00 |
DisclosureSEC source: 0001552022-25-000006 · wk-form4_1760044161.xml · derivative · entry 5 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,859.5502 Underlying: Common Shares · 43.3514 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. F5 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:09 UTC |
Friesner JacquelineSee Remarks
|
GrantPerformance Share Units · Derivative | 154.6653 | $0.00 | $0.00 |
DisclosureSEC source: 0001552051-25-000005 · wk-form4_1760044145.xml · derivative · entry 9 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,337.4844 Underlying: Common Shares · 154.6653 shares Expires 2028-03-15 F11 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs have a performance period beginning February 28, 2025 and ending on February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:09 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 40.4515 | $0.00 | $0.00 |
DisclosureSEC source: 0001552051-25-000005 · wk-form4_1760044145.xml · derivative · entry 8 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,534.4822 Underlying: Common Shares · 40.4515 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share units represent a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest in equal annual installments. The vesting will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. F10 · derivative.expiration_date: These restricted share units vest in equal annual installments. The vesting will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:09 UTC |
Friesner JacquelineSee Remarks
|
GrantPerformance Share Units · Derivative | 155.0309 | $0.00 | $0.00 |
DisclosureSEC source: 0001552051-25-000005 · wk-form4_1760044145.xml · derivative · entry 7 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,378.4611 Underlying: Common Shares · 155.0309 shares Expires 2027-03-15 F9 · derivative.exercise_price: The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:09 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 46.9128 | $0.00 | $0.00 |
DisclosureSEC source: 0001552051-25-000005 · wk-form4_1760044145.xml · derivative · entry 6 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,258.7682 Underlying: Common Shares · 46.9128 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share units represent a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F8 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. F8 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:09 UTC |
Friesner JacquelineSee Remarks
|
GrantPerformance Share Units · Derivative | 129.8034 | $0.00 | $0.00 |
DisclosureSEC source: 0001552051-25-000005 · wk-form4_1760044145.xml · derivative · entry 5 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,550.5443 Underlying: Common Shares · 129.8034 shares Expires 2026-02-22 F6 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:09 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 34.0827 | $0.00 | $0.00 |
DisclosureSEC source: 0001552051-25-000005 · wk-form4_1760044145.xml · derivative · entry 4 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,820.5585 Underlying: Common Shares · 34.0827 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share units represent a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026. F5 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:09 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 18.3531 | $0.00 | $0.00 |
DisclosureSEC source: 0001552051-25-000005 · wk-form4_1760044145.xml · derivative · entry 3 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,057.3195 Underlying: Common Shares · 18.3531 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share units represent a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F4 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. F4 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
Kobza JoshuaChief Executive Officer
|
GrantPerformance Share Units · Derivative | 1,406.1043 | $0.00 | $0.00 |
DisclosureSEC source: 0001574771-25-000005 · wk-form4_1760044102.xml · derivative · entry 10 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 157,619.7535 Underlying: Common Shares · 1,406.1043 shares Expires 2028-03-15 F12 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs have a performance period ending February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance period. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
Kobza JoshuaChief Executive Officer
|
GrantRestricted Share Units · Derivative | 178.9931 | $0.00 | $0.00 |
DisclosureSEC source: 0001574771-25-000005 · wk-form4_1760044102.xml · derivative · entry 9 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,064.5445 Underlying: Common Shares · 178.9931 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F11 · derivative.exercise_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. F11 · derivative.expiration_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
Kobza JoshuaChief Executive Officer
|
GrantPerformance Share Units · Derivative | 1,130.8597 | $0.00 | $0.00 |
DisclosureSEC source: 0001574771-25-000005 · wk-form4_1760044102.xml · derivative · entry 8 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,765.7234 Underlying: Common Shares · 1,130.8597 shares Expires 2027-03-15 F10 · derivative.exercise_price: The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
Kobza JoshuaChief Executive Officer
|
GrantRestricted Share Units · Derivative | 217.8085 | $0.00 | $0.00 |
DisclosureSEC source: 0001574771-25-000005 · wk-form4_1760044102.xml · derivative · entry 7 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,415.6336 Underlying: Common Shares · 217.8085 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F9 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. F9 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
Kobza JoshuaChief Executive Officer
|
GrantPerformance Share Units · Derivative | 2,931.4232 | $0.00 | $0.00 |
DisclosureSEC source: 0001574771-25-000005 · wk-form4_1760044102.xml · derivative · entry 6 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 328,603.0792 Underlying: Common Shares · 2,931.4232 shares Expires 2028-05-21 F7 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning February 22, 2023 and ending May 21, 2028 and to the extent earned will vest on May 21, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
Kobza JoshuaChief Executive Officer
|
GrantRestricted Share Units · Derivative | 126.6179 | $0.00 | $0.00 |
DisclosureSEC source: 0001574771-25-000005 · wk-form4_1760044102.xml · derivative · entry 5 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,193.4623 Underlying: Common Shares · 126.6179 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F6 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026. F6 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
Kobza JoshuaChief Executive Officer
|
GrantRestricted Share Units · Derivative | 77.6226 | $0.00 | $0.00 |
DisclosureSEC source: 0001574771-25-000005 · wk-form4_1760044102.xml · derivative · entry 4 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,701.2447 Underlying: Common Shares · 77.6226 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. F5 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantPerformance Share Units · Derivative | 562.4435 | $0.00 | $0.00 |
DisclosureSEC source: 0001594977-25-000006 · wk-form4_1760044114.xml · derivative · entry 11 Schwan Axel · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,048.1069 Underlying: Common Shares · 562.4435 shares Expires 2028-03-15 F11 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs will have a performance period beginning February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 110.7489 | $0.00 | $0.00 |
DisclosureSEC source: 0001594977-25-000006 · wk-form4_1760044114.xml · derivative · entry 10 Schwan Axel · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,414.5965 Underlying: Common Shares · 110.7489 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. F10 · derivative.expiration_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantPerformance Share Units · Derivative | 502.6001 | $0.00 | $0.00 |
DisclosureSEC source: 0001594977-25-000006 · wk-form4_1760044114.xml · derivative · entry 9 Schwan Axel · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,339.8497 Underlying: Common Shares · 502.6001 shares Expires 2027-03-15 F9 · derivative.exercise_price: The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 94.9147 | $0.00 | $0.00 |
DisclosureSEC source: 0001594977-25-000006 · wk-form4_1760044114.xml · derivative · entry 8 Schwan Axel · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,639.6358 Underlying: Common Shares · 94.9147 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F8 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. F8 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantPerformance Share Units · Derivative | 721.1301 | $0.00 | $0.00 |
DisclosureSEC source: 0001594977-25-000006 · wk-form4_1760044114.xml · derivative · entry 7 Schwan Axel · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,836.3575 Underlying: Common Shares · 721.1301 shares Expires 2026-02-22 F6 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 76.6372 | $0.00 | $0.00 |
DisclosureSEC source: 0001594977-25-000006 · wk-form4_1760044114.xml · derivative · entry 6 Schwan Axel · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,590.7798 Underlying: Common Shares · 76.6372 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026. F5 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 35.2858 | $0.00 | $0.00 |
DisclosureSEC source: 0001594977-25-000006 · wk-form4_1760044114.xml · derivative · entry 5 Schwan Axel · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,955.4214 Underlying: Common Shares · 35.2858 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F4 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. F4 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
Fulton DuncanChief Corporate Officer
|
GrantPerformance Share Units · Derivative | 210.9008 | $0.00 | $0.00 |
DisclosureSEC source: 0001908102-25-000004 · wk-form4_1760044128.xml · derivative · entry 10 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,646.3258 Underlying: Common Shares · 210.9008 shares Expires 2028-03-15 F13 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs have a performance period beginning on February 28, 2025 and ending on February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
Fulton DuncanChief Corporate Officer
|
GrantRestricted Share Units · Derivative | 57.4642 | $0.00 | $0.00 |
DisclosureSEC source: 0001908102-25-000004 · wk-form4_1760044128.xml · derivative · entry 9 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,442.9249 Underlying: Common Shares · 57.4642 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F5 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F12 · derivative.exercise_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. F12 · derivative.expiration_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
Fulton DuncanChief Corporate Officer
|
GrantPerformance Share Units · Derivative | 187.8496 | $0.00 | $0.00 |
DisclosureSEC source: 0001908102-25-000004 · wk-form4_1760044128.xml · derivative · entry 8 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,061.8168 Underlying: Common Shares · 187.8496 shares Expires 2027-03-15 F11 · derivative.exercise_price: The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
Fulton DuncanChief Corporate Officer
|
GrantRestricted Share Units · Derivative | 68.2521 | $0.00 | $0.00 |
DisclosureSEC source: 0001908102-25-000004 · wk-form4_1760044128.xml · derivative · entry 7 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,652.4707 Underlying: Common Shares · 68.2521 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F5 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. F10 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
Fulton DuncanChief Corporate Officer
|
GrantPerformance Share Units · Derivative | 212.7084 | $0.00 | $0.00 |
DisclosureSEC source: 0001908102-25-000004 · wk-form4_1760044128.xml · derivative · entry 6 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,849.0026 Underlying: Common Shares · 212.7084 shares Expires 2026-02-22 F8 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F9 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
Fulton DuncanChief Corporate Officer
|
GrantRestricted Share Units · Derivative | 43.423 | $0.00 | $0.00 |
DisclosureSEC source: 0001908102-25-000004 · wk-form4_1760044128.xml · derivative · entry 5 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,868.619 Underlying: Common Shares · 43.423 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F5 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F7 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026. F7 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025 and December 15, 2026. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
Fulton DuncanChief Corporate Officer
|
GrantRestricted Share Units · Derivative | 28.4873 | $0.00 | $0.00 |
DisclosureSEC source: 0001908102-25-000004 · wk-form4_1760044128.xml · derivative · entry 4 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,194.0152 Underlying: Common Shares · 28.4873 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F5 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F6 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. F6 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 31, 2025. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantPerformance Share Units · Derivative | 667.6935 | $0.00 | $0.00 |
DisclosureSEC source: 0001829353-25-000004 · wk-form4_1760044108.xml · derivative · entry 12 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,846.2871 Underlying: Common Shares · 667.6935 shares Expires 2030-05-21 F13 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025-2 PBRSUs") granted to the Reporting Person. The 2025-2 PBRSUs will have a performance period beginning May 15, 2025 and ending May 21, 2028 and to the extent earned will vest on May 21, 2030. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantPerformance Share Units · Derivative | 632.741 | $0.00 | $0.00 |
DisclosureSEC source: 0001829353-25-000004 · wk-form4_1760044108.xml · derivative · entry 11 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,928.2212 Underlying: Common Shares · 632.741 shares Expires 2028-03-15 F12 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025-1 PBRSUs") granted to the Reporting Person. The 2025-1 PBRSUs will have a performance period beginning February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantRestricted Share Units · Derivative | 92.0311 | $0.00 | $0.00 |
DisclosureSEC source: 0001829353-25-000004 · wk-form4_1760044108.xml · derivative · entry 10 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,316.3838 Underlying: Common Shares · 92.0311 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F11 · derivative.exercise_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. F11 · derivative.expiration_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2025, December 15, 2026, December 15, 2027 and December 15, 2028. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantPerformance Share Units · Derivative | 439.7751 | $0.00 | $0.00 |
DisclosureSEC source: 0001829353-25-000004 · wk-form4_1760044108.xml · derivative · entry 9 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,297.3684 Underlying: Common Shares · 439.7751 shares Expires 2027-03-15 F10 · derivative.exercise_price: The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 21:08 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantRestricted Share Units · Derivative | 99.0254 | $0.00 | $0.00 |
DisclosureSEC source: 0001829353-25-000004 · wk-form4_1760044108.xml · derivative · entry 8 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,100.4283 Underlying: Common Shares · 99.0254 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F9 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. F9 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2025, December 15, 2026 and December 15, 2027. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.